LG Introduces Its Ultra-Large 292 Cm (115") QNED evo AI Mini LED TV In India – The Giant Of Entertainment

* Powered by the Alpha 8 AI Processor Gen3, LG’s largest 2026 QNED evo TV brings the cinema, the stadium and the gaming arena into Indian living rooms, with certified 100 percent colour volume, Precision Dimming Ultra and Motion Booster up to 330Hz

News Summary

· LG Electronics India introduces the 292 cm (115") QNED evo AI Mini LED TV, the largest model in its 2026 QNED evo lineup.

· Bringing the cinema home: Precision Dimming Ultra, Dynamic QNED Color Pro with Intertek-certified 100 percent colour volume and AI Super Upscaling deliver deep contrast, rich colour and crisp 4K detail across the ultra-large screen.

· Recreating the stadium atmosphere: AI Sound Pro with virtual 11.1.2-channel surround sound and real-time sports updates on webOS 26 bring the energy of the stadium to live matches at home.

· Elevating gaming immersion: VRR up to 165Hz, Motion Booster up to 330Hz, AMD FreeSync™ Premium and Auto Low Latency Mode keep fast-paced games smooth and responsive.

· Large-screen entertainment, made smarter: webOS 26 adds AI-based personalisation, including Voice ID, AI Concierge and multi-AI support, all secured by LG Shield.

The Giant of Entertainment Comes to Indian Homes

LG Electronics India Limited (LGEIL) today introduced its 292 cm (115") QNED evo AI Mini LED TV, the largest model in its 2026 QNED evo lineup. Positioned as the giant of entertainment, the TV is built for viewers who want a bigger and more immersive way to watch, bringing the scale of the cinema, the energy of the stadium and the intensity of gaming into the living room.

Powered by LG’s Alpha 8 AI Processor Gen3, the 292 cm (115") QNED evo combines Mini LED picture quality with AI-based picture and sound technologies, so that colour, contrast and detail hold up across every inch of the ultra-large screen.

Brian Jung, Director – Media Entertainment Solution, LG Electronics India, said: “The 292 cm (115")QNED evo Mini LED TV reflects our commitment to creating more immersive home entertainment experiences. By combining ultra-large screen technology with enhanced picture quality, AI-powered sound and advanced gaming features, we are giving consumers new ways to enjoy their favourite sports, movies and games at home. True to its name as the giant of entertainment, it brings the scale of the cinema, the energy of the stadium and the thrill of gaming together on one screen.

One Screen, Four Big Experiences

Bringing the Cinema Home

On a screen this large, picture quality has to work harder. The 292 cm (115") QNED evo uses Precision Dimming Ultra to control thousands of local dimming zones, revealing fine detail in dark scenes while keeping bright highlights crisp. The result is deeper blacks, cleaner highlights and stronger contrast, with depth preserved even in shadow-heavy scenes.

Dynamic QNED Color Pro optimises colour mapping, so tones stay rich and accurate even in bright HDR scenes. It is certified by Intertek for 100 percent Color Volume1, enabling faithful colour reproduction across the full 292 cm (115") screen.

The Alpha 8 AI Processor Gen3, which draws on 13 years of LG OLED leadership to bring LG’s OLED light-control capability to QNED, also powers AI Super Upscaling. Using deep learning, it analyses on-screen objects and refines texture, edges and fine detail, so 4K visuals look natural and stay crisp on the big screen. AI Picture Pro enhances faces, bodies and other key elements to improve perceived depth, while Dynamic Tone Mapping Pro analyses each frame to refine resolution, brightness and clarity.

Recreating the Stadium Atmosphere

The 292 cm (115") QNED evo is built to make live sport feel bigger. Its wide colour range adds impact to bright sports scenes, while AI Sound Pro creates virtual 11.1.2-channel surround sound through the TV’s built-in speakers, delivering clearer spatial separation and a more immersive soundstage. Together with AI Super Upscaling and Dynamic Tone Mapping Pro, it brings a stadium-scale experience to sports and big-action content.

With the webOS 26 platform, fans can also keep up with the game without leaving the screen. Sports Portal brings live content, scores, match schedules and league standings into one place, and Sports Alert sends notifications for chosen teams and leagues. Key stats such as match progress and game-result predictions appear on an on-screen AI Concierge card, helping viewers follow several games at once.

Elevating Gaming Immersion

For gamers, the 292 cm (115") QNED evo turns its ultra-large screen into a responsive gaming display. It supports variable refresh rate (VRR) up to 165Hz, AMD FreeSync™ Premium and Auto Low Latency Mode (ALLM), keeping rapid in-game action sharp, highly responsive and free of lag.

The new Motion Booster raises the refresh rate to 330Hz, significantly reducing motion blur and keeping visuals smooth in fast-paced shooters and racing games, where split-second reactions matter. LG Gaming Portal adds an all-in-one destination with access to thousands of cloud gaming services and native web games.

Giant-Screen Entertainment, Made Smarter

As the largest model in LG’s 2026 QNED evo lineup, the 292 cm (115") TV pairs its scale with AI-based personalisation on webOS 26. With Voice ID, the TV recognises each user and automatically loads their personalised My Page home screen. AI Concierge gives context-aware suggestions and quick access to useful functions based on what is being watched. Multi-AI support, powered by Google Gemini and Microsoft Copilot, lets users ask questions, check information and search for related content while watching.

All of this is secured by LG Shield, a CES 2026 Innovation Award-winning technology that uses advanced encryption to keep user data and personalised experiences safe.

Sonata Gold Reimagines The Timeless Appeal Of Gold For Dhanteras

* Featuring a 22K gold coin and refined design details, the collection celebrates gold as a symbol of prosperity and new beginnings

Sonata introduces the latest evolution of its Sonata Gold collection, bringing an elevated design language and fresh colour variations to its gold-led offerings for Dhanteras. Rooted in the enduring significance of gold as a symbol of prosperity, good fortune and new beginnings, the collection reimagines a traditional festive season through contemporary design and everyday functionality. With its refined detailing, the new Sonata Gold collection brings a personal dimension to festive dressing, bringing the sentiment of gold into a timepiece that can be worn and cherished beyond the festive season. Blending traditional significance with everyday utility, the collection makes for a meaningful addition to festive purchases, one that brings together personal style and the spirit of the occasion.

The new Sonata Gold collection is available in two fresh hues, blue and green, complemented by a striking gold-tone bezel. A beautifully pressed dial pattern adds depth, while the 22K gold coin at the bottom centre, framed by an outline ring, serves as the defining element of each timepiece. At a time when gold prices are approximately ₹14,400 per gram, the collection seeks to make gold buying more accessible, offering consumers a contemporary way to embrace the tradition of purchasing gold during Dhanteras.

Each watch makes for a thoughtful way to mark the spirit of Dhanteras. Intricate crown detailing, along with refined indices, a redesigned minute ring and improved hands, lends the watches a polished finish while enhancing dial readability. Blending the cultural significance of gold with fashion forward design, the collection offers a distinctive timepiece for consumers looking to carry the spirit of auspicious occasions into everyday life.

Pulak Narain, Brand Head - Sonata, Titan Company Limited, said, “Sonata Gold has been the flagship offering from Sonata, which brings together craftsmanship of design, and value of gold that associates very well with the auspicious occasion of Dhanteras. Sonata Gold gives our customers an opportunity to own something valuable and traditional yet lasts beyond the occasion. The new Sonata Gold collection that we are launching on the occasion of Dhanteras this year takes the product a step forward, with much more emphasis on design, premium materials and thoughtful elements that lend a modern look to the collection while still being rooted in tradition and ethnicity. We are sure this collection will resonate very well with our customers and Sonata Gold will continue to be the bestseller for us that it has always been.”

The collection brings together thoughtful craftsmanship and everyday versatility. Whether chosen as a personal purchase for Dhanteras or as a gift for a loved one, the new Sonata Gold collection offers a modern way to carry forward a cherished tradition.

Priced at INR 8,695 onwards, the new Sonata Gold collection will be available across Titan World stores, authorised retail outlets and leading e-commerce platforms and online, offering a modern heirloom-inspired expression of gold for the festive season.

i-choose India’s first Ovulation Testing Kit Launches New Campaign On How Timing Is Key To Conception

* Conceptualised by McCann India, the campaign introduces the kit as a simple, science-backed way to conceive

* Campaign films: https://youtu.be/C39GRGOBflM; https://youtu.be/mKwasu0L57w

i-choose, India’s first Ovulation Testing Kit, has launched a new campaign, ‘The Pre-pregnancy Test,’ starring brand ambassador Shriya Pilgaonkar. Conceptualised by McCann India, part of Omnicom Advertising India, the campaign encourages couples trying to conceive to move beyond guesswork and better understand when to try.

Most couples are familiar with a pregnancy test, the test they take after trying. Far fewer think about the test that can come before it. By positioning the i-choose Ovulation Testing Kit as ‘The Pre-pregnancy Test,’ the campaign makes ovulation testing easier to understand and more relevant to them who are in the trying-to-conceive journey. The at-home test helps identify the 5 best days to try for a baby, helping couples make more informed decisions around timing.
The campaign stems from a simple consumer insight: when trying to conceive, couples often make several changes in their effort to do everything right, from eating healthier and exercising to improving their daily routines but may overlook the importance of knowing when to try. i-choose aims to encourage couples to incorporate ovulation testing as a habit into their journey of trying for a baby. “Don’t try harder. Try smarter” forms the creative approach to bring this message alive, shifting the conversation from simply doing more to being better informed about the right time to try.

One of the campaign films brings this thought alive through the warmth of sisterhood. Shriya Pilgaonkar plays a trusted friend who finds her friend attempting fertility yoga as part of her efforts to conceive. Seeing her struggle with the routine, Shriya introduces her to the i-choose Ovulation Testing Kit and the idea of the ‘Pre-pregnancy Test’, explaining how it can help identify her 5 best days to try. Through light humour and an easy conversation between friends, the film shows that while couples may be doing several things as part of their conception journey, understanding their fertile window is an important step to consider.

A second film takes the conversation into the bedroom and brings the couple’s dynamic into focus. Shriya Pilgaonkar shows her husband the ovulation testing stick, which he initially mistakes for a pregnancy test. She playfully introduces it as the ‘Pre-pregnancy Test’ and explains that it helps identify her 5 best days to try for a baby. The film uses chemistry and humour to make a typically clinical conversation around ovulation more natural and relatable, while reinforcing that trying for a baby is a journey couples can navigate together.
Commenting on the launch, Abhishek Kumar Shrivastav, CMO, Piramal Consumer Healthcare, At i-choose, we believe that making informed choices begins with having the right information. When couples plan to conceive, much of the focus is on lifestyle changes and preparing for pregnancy, while understanding the right time to try often gets overlooked. With ‘The Pre-pregnancy Test’, we want to bring this missing piece into the conversation and encourage couples to see ovulation testing as an integral part of their conception journey. The campaign is designed to challenge existing perceptions through a relatable, light-hearted narrative that makes an important scientific insight easy to understand and act on.

Adding on, Anusheela Saha, Head of Creative, McCann India, said, “The journey to pregnancy can often become a checklist for many couples, making it feel like hard work. That became the heart of our campaign: Don't try harder. Try smarter. We wanted to make this thought feel less like medical advice and more like a piece of advice you'd get from a trusted friend. So, through Shriya Pilgaonkar and the warmth of sisterhood, we bring a little humour to a journey that can often feel stressful and overwhelming, while introducing ovulation testing as a simple, science-backed step to know your best days to try and an important step in this journey.”
The campaign is live across digital platforms including YouTube, Instagram and Facebook.
Team Credits

Creative: Rahul Mathew, Anusheela Saha, Atin Ahluwalia, Shalmali Sawant, Ritviz Kumar, Riya Nippani, Ananya Jain, Kshitij Chandel
Business: Dheeraj Sinha, Hari Krishnan, Monideepa Nandi, Kashish Bachani, Sankalp Grover
Strategy: Menaka Menon, Sanjana Chetan
Director: Ayushi Anand
Production House: Mothership

About Piramal Consumer Healthcare:

Piramal Consumer Healthcare portfolio comprises 25+ brands with offerings spanning across multiple wellness categories. It aims to be among the top three Consumer Healthcare companies in India. Over the last two years, the business has invested significantly in various growth levers. The Company’s strategy of expanding the product portfolio and distribution network has worked well and the Consumer Healthcare business is evolving into a strong player in India’s Consumer Healthcare market.

For more information visit: Piramal Pharma Consumer Healthcare

About Piramal Pharma Limited
Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and the Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL's associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market.

For more information, visit: Piramal Pharma | LinkedIn

TCFM Completes 10 Years, Scales Operations To 140 Mn Sq Ft Across 30 Cities

* From a 500-member workforce in 2016 to 15,000 professionals and 200+ client sites, TCFM charts a decade of expansion from workforce partner to integrated facility management.

What began in 2016 as a dedicated workforce capability within the Embassy Services ecosystem has since evolved into a comprehensive facility management organisation, spanning integrated facility management and specialised services. Over the past decade, TCFM (Technique Control Facility Management) has expanded its scale, capabilities and geographic footprint, emerging as a significant player in India’s evolving facility management landscape.

Over the following decade, that evolution has been shaped by a series of defining business milestones.

10 Years. 10 Defining Milestones

1. 2016 | The Foundation

TCFM became part of Embassy Services Private Limited (ESPL) in 2016, establishing a dedicated workforce capability for facility and property management. The move was anchored in the need for greater control over workforce governance, training, compliance and service delivery, while strengthening ESPL’s broader approach to building critical capabilities in-house.

2. Workforce | 500 to 15,000

From an initial workforce of approximately 500, TCFM has grown to 16,000 over the past decade. Beyond the 30x manpower increase, this growth reflects the organisation’s focus on developing a professionally governed, increasingly skilled workforce capable of supporting complex facility operations.

3. Geographic Expansion | 30 Cities, 12 States

TCFM expanded from its initial operating footprint to 30 cities across 12 states, creating a wider delivery network to support clients across diverse operating environments. This geographic expansion has accompanied the company’s growing presence across commercial, manufacturing, healthcare and hospitality sectors.

4. Client Scale | 200+ Clients Locations

Over the decade, TCFM has built a portfolio of more than 200 client locations across the broader real estate ecosystem. Its sectoral growth has particularly accelerated across commercial, manufacturing, healthcare and hospitality, with each segment adding new operational complexities and broadening the organisation’s delivery expertise.

5. Scale of Operations | 140 Mn Sq Ft

TCFM today manages more than 140 million sq. ft., marking a significant expansion in the scale and complexity of its operations. The growth in managed area has required the organisation to build stronger processes, governance mechanisms and specialised capabilities that can operate consistently across a diverse portfolio.

6. Capability Expansion | TCFM Plus

TCFM’s evolution has extended beyond the traditional integrated facility management model. The introduction of our new service line - TCFM Plus brings together specialised capabilities across safety, compliance, training, audits and specialised cleaning, enabling the organisation to address a wider range of operational requirements under an integrated framework.

7. Operating Governance | 80+ SOPs

As its footprint expanded, TCFM strengthened the governance architecture supporting service delivery. Today, its operating framework includes 80 SOPs, alongside 230+ annual site audits, 350+ site due diligences and 104+ annual site transitions—creating greater process discipline and consistency across its operations.

8. People & Skilling | 3,700+ Training Sessions

Building workforce capability has remained central to TCFM’s growth. The organisation conducts more than 3,700 training sessions annually, supported by five training centres, 100+ training modules and 8,000+ onsite training hours. This structured learning ecosystem is designed to build a workforce equipped for the increasingly sophisticated requirements of modern facility management.

9. Technology | Data-led FM

Technology has increasingly become an enabler of TCFM’s operating model, helping move facility management from reactive service delivery towards greater visibility and data-led decision-making. Its technology ecosystem includes IFMS dashboards, IoT/BMS integration, digital reporting and monitoring systems, alongside technology-enabled audits and operational processes.

10. Standards & Certifications | 4 ISO Certifications

With scale has come a greater focus on standardisation, accountability and operational discipline. TCFM has built its operating framework around established processes and holds four ISO certifications, reinforcing its focus on consistent service delivery and structured operational practices across its growing footprint.

Dharmvir Singh, Country Head, TCFM, said, “The next phase of facility management will be defined by how effectively we integrate people, processes, technology and governance to meet evolving business needs. At TCFM, we are building on our operational experience by strengthening our specialised service capabilities through initiatives such as TCFM Plus, investing in skilling, enhancing governance and adopting technology to improve visibility and consistency across operations. Our focus is on building a future-ready organisation that delivers quality, meets evolving regulatory and ESG requirements, and creates sustainable value for our clients. As the industry evolves, our priority remains to strengthen our capabilities while keeping our people at the centre of our growth.”

About Technique Control Facility Management (TCFM): Technique Control Facility Management (TCFM), a subsidiary of Embassy Services Private Limited (ESPL), is one of India's leading Integrated facility management companies. TCFM manages over 140 million sq. ft. of real estate across 12 states, supported by a workforce of 16,000+ professionals trained through its state-of-the-art practical training facility, Gurukul.

The company delivers a comprehensive suite of services including housekeeping, technical services, landscaping and horticulture, office support services, and security services solutions across commercial, co-working, residential, manufacturing, co-living, industrial, warehousing, infrastructure, pharma, education, hospitality, healthcare, and energy sectors.

Capgemini Record Robust Revenues In Outlook For Q3 2026

* The announcement highlights continued demand for AI-led transformation, enterprise-wide AI deployment and modernisation of technology and data foundations.

Q3 2026 revenues of €6,073 million, up +11.7% at constant exchange rates*

9M 2026 revenues of €18,155 million, up +11.4% at constant exchange rates

Q3 2026 bookings of €5,401 million, up +3.4% at constant exchange rates

Upgraded 2026 financial targets

Constant currency revenue growth* of +9.0% to +9.5% (was around +8.5% to +9.0%)

Operating margin* of 13.6% to 13.8% (unchanged)

Organic free cash flow* of around €1.8 billion to €1.9 billion (unchanged).

The Capgemini Group reported Q3 2026 revenues of €6,073 million, up +12.6% at current exchange rates and +11.7% at constant exchange rates[*].

Aiman Ezzat, Chief Executive Officer of the Capgemini Group, said: “Capgemini delivered another solid quarter, with growth of +11.7% at constant exchange rates and underlying growth close to Q2, once again outperforming the industry. In a stable demand environment, we continue to see strong momentum in North America and the United Kingdom, and a clear acceleration in France.

Our strategy, focused on the new value pools created by AI, is translating into tangible business traction. Clients are now focused on deploying AI at enterprise scale, while addressing challenges related to governance, cost and security. This is driving demand for the modernization of their technology and data foundations, the critical prerequisite for the agentic enterprise. At the same time, clients are transforming their business operations with agentic AI, as reflected in another quarter of double-digit like-for-like growth in Intelligent Business Operations, strengthened by WNS’s scale and capabilities. We are also capturing opportunities in the defense sector and around sovereignty, as clients place greater emphasis on control and strategic resilience.

Capgemini is uniquely positioned to make AI real for its clients, combining technology, deep industry expertise, business transformation and operational execution, and increasingly leveraging an expanded partner ecosystem. We expect to maintain this momentum and target, on a higher comparison basis, a constant currency growth of 3% to 4% in Q4. On the strength of this quarter, we are raising our 2026 revenue growth target to +9.0% to +9.5% at constant exchange rates, while confirming our operating margin and organic free cash flow objectives.”

 

Key figures

	Revenues			Year-on-year change
(in millions of euros)	2025	2026		reported	at constant exchange rates
Q3	5,393	6,073		+12.6%	+11.7%
9 months	16,500	18,155		+10.0%	+11.4%

The Group reported revenues of €6,073 million in Q3 2026, up +12.6% year-on-year. Excluding the +0.9% tailwind from currency fluctuations, constant currency growth* was +11.7%, reflecting solid underlying growth complemented by the contribution of WNS and Cloud4C.

The Group continued to execute strongly against the strategy presented at its Capital Markets Day. Clients are increasingly focused on AI transformation and scaling deployments enterprise-wide. This is driving growing demand for the modernization of their technology foundations and the deployment of the new agentic tech stack, while opening new opportunities to redesign and transform business operations with agentic AI.

With bookings of €5,401 million in Q3, up +3.4% year-on-year at constant exchange rates, the Group demonstrated good commercial momentum.

 

Operations by Region

		Revenues				Year-on-year growth
		Q3 2026 (in millions of euros)				reported		at constant exchange rates
North America		1,843				+19.5%		+18.3%
United Kingdom and Ireland		928				+26.6%		+25.2%
France		1,019				+4.9%		+4.9%
Rest of Europe		1,686				+3.7%		+3.4%
Asia-Pacific and Latin America		597				+14.8%		+11.9%
TOTAL		6,073				+12.6%		+11.7%

 

The Group’s underlying growth (i.e. excluding the impact of acquisitions) in Q3 2026 was solid, supported by the positive momentum in North America and the United Kingdom, as well as continued improvements in France and the Rest of Europe. Acquisitions (notably WNS and Cloud4C closed in Q4 2025) had a material contribution to growth in the North America, United Kingdom & Ireland and Asia-Pacific regions.

In Q3 2026 and at constant exchange rates, revenues in North America (29% of 2025 Group revenues) grew +18.3% year-on-year, led by continued momentum in Financial Services, alongside strong performances in Manufacturing and Consumer Goods & Retail.

The United Kingdom and Ireland region (13% of 2025 Group revenues) posted revenue growth of +25.2% with strong traction in the Public Sector and a very dynamic Consumer Goods & Retail sector while TMT declined.

France (19% of 2025 Group revenues) continued its recovery, with revenues up by +4.9% year-on-year. Growth was primarily driven by Manufacturing and Financial Services, even as the Public Sector remained weak.

Revenues in the Rest of Europe region (30% of 2025 Group revenues) rose by +3.4%. The Public, Energy & Utilities and Services sectors all grew strongly, and Manufacturing turned slightly positive.

Finally, revenues in the Asia-Pacific and Latin America region (9% of 2025 Group revenues) increased +11.9%, supported by the contribution of WNS and Cloud4C, with good growth in the Financial Services and Consumer Goods & Retail sectors.

 

Operations by Business

	Total revenues	Q3 2026 Year-on-year growth in Total revenues of the business*
	(% of 2025 Group revenues)	at constant exchange rates
Strategy & Transformation	8%	+18.6%
Applications & Technology	63%	+3.5%
Operations & Engineering	29%	+26.9%

At constant exchange rates, Strategy & Transformation (8% of 2025 Group revenues) reported +18.6% growth in total revenues in Q3 2026. This strong performance reflects the growing demand for business transformation in the era of agentic AI, as clients redesign their enterprise processes around AI, and the relevance of Capgemini’s deep industry expertise and understanding of clients’ business challenges.

Applications & Technology (63% of 2025 Group revenues and Capgemini’s core business) reported total revenue growth of +3.5%, supported by continued demand for the modernization of legacy technologies, a critical prerequisite for building the new agentic technology stack.

Finally, total revenues in Operations & Engineering (29% of 2025 Group revenues) increased +26.9%, with double-digit growth on a like-for-like basis in Intelligent Business Operations, with strong performance across Capgemini and WNS activities.

Headcount

As of September 30, 2026, the Group’s total headcount stood at 417,500, up 62,800 or +18% year-on-year, primarily reflecting the integration of WNS team members, and down 5,900 compared to the end of 2025.

The onshore workforce was 141,900 employees. The offshore workforce was 275,600 employees, stable at 66% of the total headcount compared to the end of 2025.

Outlook

The Group’s financial targets for 2026 are updated as follows:

Revenue growth of +9.0% to +9.5% at constant exchange rates (was around +8.5% to +9.0%). The inorganic contribution is estimated at around 5 points (unchanged);

Operating margin of 13.6% to 13.8% (unchanged);

Organic free cash flow of around €1.8 billion to €1.9 billion (unchanged).

The organic free cash flow target takes into account an increase in restructuring cash outflow of around €200 million compared to 2025 related to the Fit-for-Growth initiatives.

Conference call

Aiman Ezzat, Chief Executive Officer, accompanied by Nive Bhagat, Chief Financial Officer, will comment on this publication during a conference call in English to be held today at 8.00 a.m. Paris time (CET). You can follow this conference call live via webcast at the following link. A replay will also be available for a period of one year.

All documents relating to this publication will be posted on the Capgemini investor website at https://investors.capgemini.com/en/. 

Provisional calendar

February 16, 2027 FY 2026 results

April 29, 2027 Q1 2027 revenues

May 20, 2027 Shareholders’ Meeting

July 28, 2027 H1 2027 results

About Capgemini

Capgemini is the business transformation partner for enterprises in the age of AI. We help organizations imagine and build an intelligent, sustainable future, combining AI, technology and human ingenuity to transform how they operate, innovate and grow. With unique end-to-end capabilities spanning strategy, technology, engineering and intelligent operations, we bring together deep industry expertise and market-leading capabilities in AI, cloud and data to turn ambition into measurable business outcomes at scale. Supported by a robust ecosystem of partners and nearly 60 years of expertise, Capgemini is a responsible and diverse global organization of over 410,000 team members in more than 50 countries. The Group reported 2025 revenues of €22.5 billion.

Make it real | www.capgemini.com

Strides Delivers Strong Performance With Q2FY27 Revenue At ₹14,297m, Grew 17% YoY

Strides Pharma’s Q2FY27 results revenue up 17.1% YoY to ₹14,297m, led by strong 31 % YoY growth in the Ex-US Markets

• US business at ₹6,855m ($73m), up 9% YoY; 3 products launched during the quarter

• Ex-US Markets revenue at ₹6,963m ($74m), up 31% YoY, surpassing the US business in quarterly revenue for the first time

• EBITDA up 8.4% YoY to ₹2,509m, crossing the ₹2,500m mark in a quarter for the first time despite higher input material and freight costs; EBITDA margin at 17.6%

• Operational PAT up 11.5% YoY to ₹1,358m; Operational EPS at ₹14.7

• Reported PAT up 2.0% YoY to ₹1,341m; Reported EPS at ₹14.2

Attached and appended below is the press release and investor presentation for your reference.

Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoY

Ex-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time

Q2FY27 Performance Highlights

• Revenue up 17.1% YoY to ₹14,297m, led by strong 31% YoY growth in the Ex-US Markets

• US business at ₹6,855m ($73m), up 9% YoY; 3 products launched during the quarter

• Ex-US Markets revenue at ₹6,963m ($74m), up 31% YoY, surpassing the US business in quarterly revenue for the first time

• EBITDA up 8.4% YoY to ₹2,509m, crossing the ₹2,500m mark in a quarter for the first time despite higher input material and freight costs; EBITDA margin at 17.6%

• Operational PAT up 11.5% YoY to ₹1,358m; Operational EPS at ₹14.7

• Reported PAT up 2.0% YoY to ₹1,341m; Reported EPS at ₹14.2

Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) today announced its consolidated financial results for the quarter (Q2FY27) and half year (H1FY27) ended 30 September, 2026.

 

Financial Highlights (In ₹m)

Particulars (₹m)	Q2FY27	Q2FY26	YoY	Q1FY27	QoQ	H1FY27	H1FY26	YoY
Revenue	14,297	12,208	17.1%	12,654	13.0%	26,951	23,406	15.1%
Gross Margin	8,003	7,056	13.4%	7,702	3.9%	15,705	13,810	13.7%
Gross Margin %	56.0%	57.8%	-180 bps	60.9%	-490 bps	58.3%	59.0%	-70 bps
EBITDA	2,509	2,316	8.4%	2,298	9.2%	4,807	4,496	6.9%
EBITDA %	17.6%	19.0%	-140 bps	18.2%	-60 bps	17.8%	19.2%	-140 bps
Operational PAT	1,358	1,218*	11.5%	1,231	10.3%	2,589	2,358*	9.8%
Operational EPS (₹)	14.7	13.2	11.6%	13.4	10.3%	28.1	25.6	9.9%
Reported PAT	1,341	1,315	2.0%	1,655	-19.0%	2,996	2,371	26.4%
Reported EPS (₹)	14.2	13.8	2.6%	17.0	-16.6%	31.2	24.6	26.7%

* Q2FY26 and H1FY26 Operational PAT and Operational EPS exclude one-time finance income of ₹185m; Operational PAT = Reported PAT excluding exceptional items

Badree Komandur, MD & Group CEO, commented on the performance and said, “Strides delivered a strong second quarter, with revenue of ₹14,297m growing ~17% YoY, driven by Ex-US Markets. Our diversification strategy continues to play out, with Ex-US Markets growing 31% YoY to ₹6,963m and, for the first time, surpassing our US business in quarterly revenue. Our US business delivered 9% YoY growth. EBITDA grew to ₹2,509m, crossing the ₹2,500m mark in a quarter for the first time. This was despite higher raw material, freight and operating costs arising from geopolitical disruptions. We remain focused on mitigating these pressures through continuous cost optimization initiatives during the year. Net Debt increased by ₹2,114m during H1 due to an elongated cash-to-cash cycle and higher inventory holding to navigate current market conditions. We expect the Net Debt to EBITDA ratio to stabilize by the end of the year. We are also pleased to welcome Mr. Biren Gabhawala to our Board as an Independent Director. His deep expertise in financial reporting, audit and corporate governance will further strengthen the Board’s oversight. While the external environment remains dynamic, we are committed to delivering sustainable and profitable growth.”

About Strides

Strides, a global pharmaceutical company headquartered in Bengaluru, India, is listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR). The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy and an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry, and two locations in Bengaluru), Italy (Milan), Kenya (Nairobi), and the United States (New York). The Company focuses on “difficult to manufacture” products sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com.